REDAFAMDASTAT
UNII H4C81M8YYW

Substance Identification & Data

This profile provides standardized clinical and technical data for Redafamdastat, uniquely identified by the FDA Unique Ingredient Identifier (UNII) H4C81M8YYW.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1020315-31-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

H4C81M8YYW

CAS Registry Number

1020315-31-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

REDAFAMDASTAT

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C23H20F3N5O2

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

BATCTBJIJJEPHM-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C203215

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

24771824

Unique identification number in the NCBI database of chemical substances.

INN ID

12589

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

N1(CCC(CC1)=Cc2cc(ccc2)Oc3ccc(cn3)C(F)(F)F)C(=O)Nc4cccnn4

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Redafamdastat. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.